Cathay Biotech Inc. (688065.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 33.94B |
| Enterprise Value | 25.19B |
| P/E Ratio | 52.58 |
| PEG Ratio | -7.8 |
| Price/Sales Ratio | 9.27 |
| Price/Book Ratio | 1.76 |
| Enterprise/Revenue | 6.82 |
| Enterprise/EBITDA | 25.83 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.18 |
| Operating Margin | 0.2 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.03 |
Income Statement
| Revenue | 3.3B |
| Revenue/Share | 4.71 |
| Gross Profit | 635.09M |
| EBITDA | 947.42M |
| Net Income | 565.72M |
| Diluted EPS | 0.83 |
Balance Sheet
| Total Cash | 9.41B |
| Total Cash/Share | 13.05 |
| Total Debt | 1.09B |
| Total Debt/Equity | 0.06 |
| Current Ratio | 5.11 |
| Book Value Per Share | 29.82 |
Price History
| 52-Week Change | -7.41 |
| 52-Week High | 64.5 |
| 52-Week Low | 39.51 |
| Moving Average 50 Days | 45.72 |
| Moving Average 200 Days | 49.76 |
Statistics
| Average Volume | 6.3M |
| Shares Outstanding | 721.29M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.4 |
| Trailing Annual Dividend Yield | 0.92 |
| Payout Ratio | 0.02 |
| Last Split Factor | 7:5 |
| Last Split Date | July 20, 2022 |
AD
